>
Acetaldehyde binding products

Acetium® – Lozenges to quit smoking

Lozenges to quit smoking without nicotine

Acetium lozenge

Quitting smoking can be challenging as cigarette smoke contains substances that reinforce smoking behaviour and make stopping a real challenge.

Acetium® lozenge is a nicotine-free smoking intervention product intended for those who want to quit smoking. Acetium® lozenge – quit smoking is devoid of the side effects of conventional smoking intervention methods (such as nicotine dependence and possible adverse side effects of medicines).

 

Acetium® lozenge – quit smoking is a CE marked medical device

 

   

 

 

→ Talk to our experts about your needs

Why acetaldehyde matters when quitting smoking?

  • Cigarette smoke contains acetaldehyde, a harmful substance that dissolves rapidly into saliva during smoking.
  • Acetaldehyde is known to support the addictive properties of smoking and plays a role in maintaining tobacco dependence.
  • Reducing acetaldehyde exposure in saliva during smoking has been shown to support smoking cessation efforts.

How Acetium® lozenge works

Acetium® lozenge works during smoking by acting locally in saliva:

  • The lozenge slowly releases L-cysteine, a natural amino acid
  • L-cysteine binds acetaldehyde in saliva
  • Acetaldehyde is converted into a harmless compound
  • This reduces acetaldehyde exposure while the lozenge dissolves in the mouth

The lozenge also contains xylitol, which supports oral hygiene.

How to use

  • Use one Acetium® lozenge every time you smoke a cigarette
  • Allow the lozenge to dissolve slowly in the mouth
  • Regular use (3-6 months) is recommended as part of a smoking cessation period, following the instructions for use.

Acetium® lozenge does not contain nicotine or medicinal drugs.

REF

REFProductQty
620430Acetium® lozenge – quit smoking10 x 30 lozenges

Acetium® lozenges and cigarette smoke acetaldehyde-related literature:

  1. Salaspuro VJ, Hietala JM, Marvola ML Salaspuro MP. Eliminating carcinogenic acetaldehyde by cysteine from saliva during smoking. Cancer Epid Biomark Prev 2006;15:146-149.
  2. Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, man C, Galichet L, Cogliano V. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 10:1033-1034.
  3. Syrjänen K, Salminen J, Aresvuo U, Hendolin P, Paloheimo L, Eklund C, Salaspuro M, Suovaniemi O. Elimination of cigarette smoke-derived acetaldehyde in saliva by slow-release L-cysteine lozenge is an effective new method to assist smoking cessation. A randomised, double-blind, placebo-controlled intervention. Anticancer Res. 2016;36:2297-2306.
  4. Syrjänen K, Eronen K, Hendolin P, Paloheimo L, Eklund C, Bäckström A, Suovaniemi O. Slow-release L-cysteine (Acetium®) lozenge is an effective new method in smoking cessation. A randomized, double-blind, placebo-controlled intervention. Anticancer Res 2017;37: 3639-3648.

 

Acetium® is a registered trademark of Biohit Oyj, Finland